Willingness to pay for a new drug delivery in Parkinson patients

OBJECTIVE: The Swedish reimbursement system operates a system where prices are set based on the expected value to the consumer. This value can be measured using willingness to pay (WTP). AIM: To assess Parkinson’s disease (PD) patients’ WTP for newly developed microtablets of levodopa in combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Lökk, Johan, Olofsson, Sara, Persson, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199841/
https://www.ncbi.nlm.nih.gov/pubmed/25336962
http://dx.doi.org/10.2147/JMDH.S67929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199841/
https://www.ncbi.nlm.nih.gov/pubmed/25336962
http://dx.doi.org/10.2147/JMDH.S67929

Ejemplares similares